Verifying analytical purity, exact molecular weight, and endotoxin thresholds is essential for rigorous laboratory experimentation. PX1 Research provides batch-specific analytical documentation to ensure every research compound meets stringent technical specifications prior to laboratory distribution.
Verifying analytical purity, exact molecular weight, and endotoxin thresholds is essential for rigorous laboratory experimentation. PX1 Research provides batch-specific analytical documentation to ensure every research compound meets stringent technical specifications prior to laboratory distribution.
An ipamorelin certificate of analysis (COA) is an analytical document issued by an independent ISO 17025-accredited laboratory verifying the identity, purity, and safety profile of a specific peptide lot. It details crucial analytical data, including Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) purity profiles, Mass Spectrometry (MS) mass identification, and Limulus Amebocyte Lysate (LAL) endotoxin quantification to ensure strict experimental reproducibility.
When evaluating a lot of ipamorelin research peptide, principal investigators and laboratory technicians must verify that the documentation matches the physical lot number printed on the product vial. Independent testing guarantees that the synthetic pentapeptide structure (Aib-His-D-2Nal-D-Phe-Lys-NH2) is uncompromised by manufacturing impurities, truncated peptide chains, or residual organic solvents.
A comprehensive analytical report for a synthetic peptide evaluates several key chemical parameters. Principal among these is chemical purity, which quantifies the proportion of the target sequence relative to related peptide impurities, such as deamidation products, oxidation species, or deletion sequences.
In addition to purity, the COA establishes positive molecular identification, total peptide content, moisture content, appearance, and biological contaminant testing. Modern laboratory quality control frameworks demand multi-method verification before reagents are cleared for *in vitro* receptor binding assays or *in vivo* animal models. For comprehensive data on synthetic workflows, researchers can consult our preclinical peptide synthesis guide.
The primary metrics verified on every PX1 Research batch report include:
1. Purity Determination (RP-HPLC): Purity percentage calculated via UV absorbance peak integration at 214 nm or 220 nm. 2. Mass Identification (ESI-MS): Confirmation of exact monoisotopic or average molecular mass against theoretical targets. 3. Endotoxin Testing (LAL Assay): Quantitative measurement of bacterial endotoxins expressed in Endotoxin Units per milligram (EU/mg). 4. Physical Appearance: Inspection of the lyophilized cake for color, uniformity, and absence of foreign particulate matter. 5. Solubility & Reconstitution: Visual verification of rapid dissolution in aqueous buffers such as sterile bacteriostatic water.
Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) serves as the industry standard for quantifying chemical purity in synthetic peptides. The technique separates molecules based on hydrophobic interactions with a non-polar stationary phase (typically C18 silica) while an aqueous-organic mobile phase gradient elutes the compound.
On an authentic ipamorelin certificate of analysis, the HPLC chromatogram displays retention time on the X-axis and UV detector response (mAU) on the Y-axis. The main chromatographic peak represents intact ipamorelin. Purity is calculated by integrating the area under the primary peak relative to the total area of all detected peaks. High-grade research reagents must yield a primary peak area corresponding to at least 98.0% of the total integrated area.
Minor secondary peaks indicate baseline impurities generated during solid-phase peptide synthesis (SPPS), such as incomplete coupling steps or side-chain deprotection artifacts. Chromatographic runs conducted under optimized TFA/acetonitrile gradient conditions ensure that closely eluting isomeric impurities are fully resolved, providing investigators with an accurate baseline assessment.
While HPLC determines compound purity, it cannot definitively confirm chemical identity. Electrospray Ionization Mass Spectrometry (ESI-MS) or Matrix-Assisted Laser Desorption/Ionization (MALDI-TOF) is required to verify the exact molecular mass of the target molecule.
Ipamorelin has a chemical formula of C38H49N9O5 and a theoretical molecular mass of 711.86 g/mol. On a standard mass spectrum report, the ionized parent molecule appears primarily as a single protonated species [M+H]+ at m/z 712.9, or as a doubly charged species [M+2H]2+/2 at m/z 356.9 depending on the ionization energy and instrument calibration.
Matching the observed mass spectrum against the theoretical molecular weight confirms that the amino acid sequence is correctly assembled without post-translational or synthetic alterations. PX1 Research includes full mass spectra alongside HPLC chromatograms for complete batch transparency across our entire PX1 research peptide catalog.
Bacterial endotoxins—specifically lipopolysaccharides (LPS) derived from the outer cell membrane of Gram-negative bacteria—pose a significant risk in cell culture and preclinical models. Presence of endotoxins can activate Toll-like receptor 4 (TLR4), causing unintended inflammatory responses, cytokine release, and cellular toxicity that confound experimental outcomes.
Endotoxin levels are quantified using the chromogenic or turbidimetric Limulus Amebocyte Lysate (LAL) assay. An exemplary ipamorelin certificate of analysis documents an endotoxin concentration strictly below established thresholds, typically < 0.05 EU/mg or < 0.1 EU/mg. This level ensures that the compound can be introduced into delicate *in vitro* assay environments or animal tissue models without triggering non-specific inflammatory signaling pathways.
Ipamorelin is a pentapeptide ghrelin receptor agonist classified within the class of growth hormone secretagogues (GHS). In preclinical animal models, ipamorelin is investigated for its ability to induce selective, pulsatile growth-hormone release without inducing significant elevations in serum cortisol or prolactin levels—a distinct pharmacodynamic profile compared to earlier-generation secretagogues.
When designing comparative research studies, investigators often contrast ipamorelin against other ghrelin receptor agonists and GHRH analogues. For instance, GHRP-6 and GHRP-2 demonstrate potent GH release but frequently trigger concurrent cortisol, prolactin, and appetite-stimulating pathways in rodent models. Conversely, GHRH peptide analogues like CJC-1295 Without DAC and Sermorelin act through the growth hormone-releasing hormone receptor (GHRHR) rather than the ghrelin receptor (GHS-R1a). Examining batch COAs across these diverse growth hormone secretagogue peptides allows researchers to confirm baseline purity standards across all experimental arms.
To preserve the analytical integrity documented on a COA, proper handling and storage protocols must be maintained upon arrival at the laboratory. Lyophilized ipamorelin should be stored at -20°C in a desiccated environment protected from light. Under these conditions, the dry peptide cake maintains chemical stability for extended durations.
When preparing the compound for assay protocols, reconstitution must occur in a sterile laminar flow hood. A suitable solvent, such as sterile bacteriostatic water for reconstitution or phosphate-buffered saline (PBS, pH 7.4), should be introduced down the inner wall of the glass vial to avoid mechanical shearing of the peptide structure. Once reconstituted, stock solutions should be aliquoted into single-use microcentrifuge tubes to prevent repeated freeze-thaw cycles, which degrade peptide bonds over time. Detailed handling guidelines are cataloged in our dedicated growth hormone secretagogue literature.
PX1 Research operates with a strict quality management standard designed specifically for institutional and independent research facilities. All peptides are synthesized in state-of-the-art, GMP-compliant facilities within the United States, adhering to rigorous process validation and environmental controls.
Every production lot undergoes comprehensive analytical verification at an independent ISO 17025-accredited laboratory. PX1 Research maintains full lot traceability, linking each shipped vial directly to its corresponding COA. To support rapid laboratory workflows, all orders ship same-day (Monday through Friday) directly from our distribution hubs in California and Arizona. University laboratories and corporate institutions requiring bulk material can register for wholesale laboratory accounts to access specialized lot reservations and customized bulk analytical packages.
What is an ipamorelin certificate of analysis?
An ipamorelin certificate of analysis (COA) is a lot-specific quality control document issued by an independent laboratory. It provides quantitative analytical data including RP-HPLC purity percentages, ESI-MS molecular mass confirmation, and LAL endotoxin testing results to verify that the compound meets strict laboratory research specifications.
Where can I find the ipamorelin certificate of analysis for my batch?
Every product lot sold by PX1 Research includes a batch-specific COA available directly on the website product page or upon request by providing the lot number located on the vial label.
What HPLC purity level should an ipamorelin COA show?
For reliable research applications, an ipamorelin COA should demonstrate a minimum HPLC purity profile of ≥98.0%. High analytical purity minimizes the presence of truncated peptide fragments or chemical impurities that could alter experimental binding affinity or cellular responses.
How is the molecular weight of ipamorelin verified on a COA?
Molecular weight is verified using Electrospray Ionization Mass Spectrometry (ESI-MS). The resulting mass spectrum must show a primary peak corresponding to ipamorelin's theoretical molecular mass of 711.86 g/mol (typically detected at m/z 712.9 for [M+H]+).
What are acceptable endotoxin limits on a peptide COA?
For cellular and preclinical research, endotoxin levels should ideally test below 0.1 EU/mg (or < 0.05 EU/mg) as measured by a Limulus Amebocyte Lysate (LAL) assay. Low endotoxin levels prevent non-specific immunological activation during testing.
Does PX1 Research perform third-party testing on ipamorelin?
Yes. Every lot of ipamorelin synthesized for PX1 Research is submitted to an independent, ISO 17025-accredited analytical testing laboratory in the USA for independent HPLC, mass spec, and endotoxin analysis prior to release.
How should lyophilized ipamorelin be stored in the lab?
Lyophilized ipamorelin should be stored at -20°C in a dry environment protected from light. Upon reconstitution with sterile diluent, liquid aliquots should be kept refrigerated at 2°C to 8°C for short-term use or frozen at -80°C for long-term storage.
What liquid should be used to reconstitute ipamorelin for laboratory testing?
Laboratory reconstitution is typically performed using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile normal saline/PBS depending on the specific protocol and cell viability requirements of the downstream assay.
Why is ipamorelin studied in growth hormone secretagogue research?
Preclinical studies suggest that ipamorelin acts as a selective ghrelin receptor agonist, stimulating pulsatile growth hormone release in animal models without inducing significant cross-reactivity with ACTH, cortisol, or prolactin secretion pathways.
How quickly do ipamorelin orders ship from PX1 Research?
PX1 Research dispatches all peptide orders same-day when placed Monday through Friday before cut-off times, shipping directly from distribution hubs located in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.